Histogen Inc.
This article was originally published in Start Up
Executive Summary
Histogen is developing an extracellular matrix aimed at the aesthetics market as well as wound healing and research applications. Its technology derives from fibroblasts isolated from newborns, which are then seeded onto a bead-like structure and provided with growth media, where they secrete extracellular matrix proteins and growth factors. Because the fibroblasts come from newborns, they proliferate more rapidly and can last longer than fibroblasts from adults.